Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1998-03-12
2000-05-23
Padmanabhan, Sreeni
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514844, 514846, 564230, 564238, A61K 31155, C07C27708
Patent
active
060666730
ABSTRACT:
The present invention relates to compounds, compositions, and methods which are useful for the prevention and treatment of adverse health, skin, hair, and oral conditions. The compounds, compositions, and methods are also widely applicable for use in health, skin, hair, oral, beauty, and personal care applications.
In particular, the present invention relates to compounds having the structure: ##STR1## and the tautomers, acceptable salts, and biohydrolyzable amides, esters, and imides thereof, wherein A, Q, n, P, L.sub.1, L.sub.2, L.sub.3, L.sub.4, Z, X, B.sub.1, and B.sub.2 are defined herein.
REFERENCES:
patent: 4021472 (1977-05-01), Fujii et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4224342 (1980-09-01), Fujii et al.
patent: 4310533 (1982-01-01), Uegai et al.
patent: 4454338 (1984-06-01), Fujii et al.
patent: 4556560 (1985-12-01), Buckingham
patent: 4570006 (1986-02-01), Fujii et al.
patent: 4745161 (1988-05-01), Saudek et al.
patent: 4746737 (1988-05-01), Fujii et al.
patent: 4873253 (1989-10-01), Okamoto et al.
patent: 4948891 (1990-08-01), Schnur et al.
patent: 5037883 (1991-08-01), Kopecek et al.
patent: 5075335 (1991-12-01), Souda et al.
patent: 5091193 (1992-02-01), Enjoiras et al.
patent: 5162307 (1992-11-01), Digenis et al.
patent: 5183660 (1993-02-01), Ikeda et al.
patent: 5352704 (1994-10-01), Okuyama et al.
patent: 5372807 (1994-12-01), Poiani et al.
patent: 5376655 (1994-12-01), Imaki et al.
patent: 5446090 (1995-08-01), Harris
patent: 5455027 (1995-10-01), Zalipsky et al.
patent: 5571844 (1996-11-01), Stuber et al.
patent: 5622984 (1997-04-01), Nakai et al.
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5648506 (1997-07-01), Desai et al.
patent: 5660822 (1997-08-01), Poiani et al.
patent: 5723133 (1998-03-01), Nagai et al.
patent: 5783178 (1998-07-01), Kabanov et al.
patent: 5840485 (1998-11-01), Lebl et al.
Bernkop-Schnurch,m et al., "Synthesis and In Vitro Evaluation of Chitosan-EDTA-Protease Inhibitor Conjugates Which Might Be Useful in Oral Delivery of Peptides and Proteins", Pharmaceutical Research, vol. 15, No. 2, pp. 263-269 (1998).
Noguchi, H., Iwata, H., Ikada, Y., "Synthesis of Monomeric and Polymeric Conjugates Carrying a Thrombin Inhibitor Through an Ester Bond", J. Biomed Mater Res, vol. 39, pp. 621-629 (1998).
Domb, A.J., Cravalho, E.G., Langer, R., "The Synthesis of Poly(hydroxamic Acid) from Poly(acrylamide)", Journal of Polymer Science; Part A, vol. 26, pp. 2623-2630 (1988).
Subr, V., Duncan, R., Hanada, K., Cable, H.C., Kopecek, J., "A Lysosomotropic Polymeric Inhibitor of Cysteine Proteinases", Journal of Controlled Release, vol. 4, pp. 63-68 (1986).
Rypacek, F., "Polymer-Bound Enzyme Inhibitors: Synthesis, Properties, and Physiological Relevance", Critical Reviews in Therapeutic Drug Carrier Systems, vol. 9(3,4), pp. 189-212 (1992).
Macfarlane, G.T., Cummings, J.H., Allison, "Protein Degradation by Human Intestinal Bacteria", Journal of General Microbiology, vol. 132, pp. 1647-1656 (1986).
Takerkart, G., Segard, E., Monsigny, M., "Preparation and Properites of Organophilic Trypsin Macro-Inhibitors: Diamidino-.alpha., .omega.-Diphenylcarbamyl-Poly(Ethylene Glycol)", FEBS Letters, vol. 42, No. 2, pp. 214-217 (1974).
Andersen, P.H., Bucher, A.P., Saeed, I., Lee, P.C., Davis, J.A., Maibach, H.I., "Faecal Enzymes: In Vivo Human Skin Irritation", Contact Dermatitis, vol. 30, pp. 152-158 (1994).
Buckingham, K.W., Berg, R.W., "Etiologic Factors in Diaper Dermatitis: The Role of Feces", Pediatric Dermatology, vol. 3, No. 2, pp. 107-112 (1986).
Berg, R.W., Buckingham, K.W., Stewart, R.L., "Etiologic Factors in Diaper Dermatitis: The Role of Urine", Pediatric Dermatology, vol. 3, No. 2, pp. 102-106 (1986).
Hans-Hartwig, O., Schirmeister, T., "Cysteine Proteases and Their Inhibitors", Chem Rev., vol. 97, pp. 133-171 (1997).
Bernkop-Schnurch, A., Apprich, I., "Synthesis and Evaluation of a Modified Mucoadhesive Polymer Protecting from .alpha.-chymotrypsinic Degradation", International Journal of Pharmaceuticals, vol. 146, pp. 247-254 (1997).
Bernkop-.sctn.chnurch, A. Gockel, N.C., "Development and Analysis of a Polymer Protecting from Luminal Enzymatic Degradation Caused by .alpha.-Chymotrypsin", Drug Development and Industrial Pharmacy, vol. 23, No. 8, pp. 733-740 (1997).
Bernkop-Schnurch, A., Bratengeyer, I., Valenta, C., "Development and In Vitro Evaluation of a Drug Delivery System Protecting from Trypsinic Degradation", International Journal of Pharmaceutics, vol. 157, pp. 17-25 (1997).
Zalipsky, S., Gilon, C., Zilkha, A., Attachment of Drugs to Polyethylene Glycols, Eur. Polym. J., vol. 19, No. 12, pp. 1177-1193 (1983).
Bates Timothy
McIver John McMillan
Underiner Todd Laurence
Echler, Sr. Richard S.
Hersko Bart S.
McDow-Dunham Kelly L.
Padmanabhan Sreeni
The Procter & Gamble & Company
LandOfFree
Enzyme inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enzyme inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837477